None

BioXpress Therapeutics, Alfred E. Tiefenbacher GmbH & Co. KG deal

BioXpress, AET BioTech enter agreement to co-develop Adalimumab biosimilar

AET BioTech, the separate biosimilars business within the generic drug developer AET (Alfred E Tiefenbacher) Group and BioXpress Therapeutics SA, a Swiss-based biotechnology company developing monoclo...

AET BioTech and BioXpress to co-develop biosimilar Humira

Plans to develop another biosimilar version of Abbott Laboratories blockbuster rheumatoid arthritis drug Humira (adalimumab) have been announced by AET BioTech, the separate biosimilars business withi...

Alfred Stern Joins Borealis Executive Board

Borealis, a provider of chemical and innovative plastics solutions, announces the appointment of Alfred Stern as Executive Vice President for Polyolefins, effective July 1, 2012. Alfred Stern succeeds...

BioXpress, AET BioTech to co-develop adalimumab biosimilar

BioXpress Therapeutics S.A. (Plan-les-Ouates, Switzerland) and AET BioTech partnered to co-develop a biosimilar version of autoimmune drug adalimumab, a human mAb against tumor necrosis factor (TNF) a...

Alfred Russel Wallace: Evolution's red-hot radical

Sidekick status does Alfred Russel Wallace an injustice. He was a visionary scientist in his own right, a daring explorer and a passionate socialist, argues Andrew Berry.

AET BioTech and BioXpress Therapeutics to Co-Develop Biosimilar Adalimumab

GZIRA, Malta, HAMBURG, Germany and GENEVA, October 30, 2012 /PRNewswire/ -- AET BioTech, the separate biosimilars business within the generic drug developer AET (Alfred E Tiefenbacher) Group and BioX...

Keystone Symposia announces grant from Alfred P. Sloan Foundation

(Keystone Symposia on Molecular & Cellular Biology) Keystone Symposia has received a grant from the Alfred P. Sloan Foundation to fund an advanced life sciences training conference in summer 2013 for...

Patient rights act : Effect on medical practice.

Evolving psychiatric diagnosis and the DSM: hasten slowly.

In Reply.

Post cardiac arrest syndrome: a review of therapeutic strategies.

Single-centre experience of donation after cardiac death.